Literature DB >> 25785170

Levels of serum superoxide dismutase and high sensitive C-reactive protein in type 2 diabetic patients with lower extremity vascular disease are enhanced by interventional treatment.

Yongxu Mu1, Ruiqiang Yan1, Xiaoyan Hu1, Junfeng He1, Haiyan Liu1, Qiming Li1.   

Abstract

OBJECTIVES: This study is to determine the levels of serum superoxide dismutase (SOD) and high sensitive C-reactive protein (hs-CRP) in type 2 diabetic patients with lower extremity vascular disease before and after interventional treatment.
METHODS: A total of 65 patients were enrolled in this study, including 35 mails and 30 females. Another 65 healthy individuals were used as control, including 41 males and 24 females. Lesions and degrees of stenosis were determined by computed tomography angiography. Contralateral iliac artery and proximal femoral artery occlusion were treated by retrograde femoral artery puncture. The levels of serum SOD and hs-CRP were determined by enzyme-linked immunosorbent assay. Correlation was analyzed by Pearson's test. Progression-free survival curve was analyzed by Kaplan-Meier method.
RESULTS: The levels of serum SOD at 20 min, 24 hr, 7 d, and 14 d after surgery were significantly decreased compared with those before surgery (P < 0.05). The levels of serum hs-CRP at 20 min and 24 hr after surgery were increased compared with those before surgery (P < 0.05). The level of serum hs-CRP at 14 d after surgery was significantly lower than that before surgery (P < 0.05). The correlation between SOD and hs-CRP was positive before surgery (r = 0.03, P < 0.001), but negative at 24 hr after surgery (r = -0.008, P < 0.001). The levels of serum SOD were significantly lower than median value (P < 0.05), while the Levels of serum hs-CRP were significantly higher than median value (P < 0.05).
CONCLUSIONS: The levels of serum SOD and hs-CRP were significantly different before and after interventional treatment. The levels of serum SOD and hs-CRP can be used as indicators for the efficacy and prognosis of interventional treatment on type 2 diabetic patients with lower extremity vascular disease.

Entities:  

Keywords:  Type 2 diabetes; high sensitivity C-reactive protein; interventional treatment; lower extremity vascular disease; superoxide dismutase

Year:  2015        PMID: 25785170      PMCID: PMC4358625     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  13 in total

Review 1.  Atherosclerosis is an inflammatory disease.

Authors:  R Ross
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

2.  The use of high sensitivity C-reactive protein in assessing the risk for coronary heart disease.

Authors:  V A Legrys
Journal:  Clin Lab Sci       Date:  2001

3.  The pathobiology of diabetic complications: a unifying mechanism.

Authors:  Michael Brownlee
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

4.  C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis.

Authors:  T P Zwaka; V Hombach; J Torzewski
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

5.  Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency.

Authors:  Nosratola D Vaziri; Michael Dicus; Nathan D Ho; Laleh Boroujerdi-Rad; Ram K Sindhu
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

Review 6.  [Type 2 diabetes mellitus as a subclinical inflammation].

Authors:  Jan Skrha
Journal:  Cas Lek Cesk       Date:  2010

7.  Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus.

Authors:  Michelle Kaefer; Sílvia J Piva; José A M De Carvalho; Dievan B Da Silva; Aline M Becker; Adriane C Coelho; Marta M M F Duarte; Rafael N Moresco
Journal:  Clin Biochem       Date:  2009-12-05       Impact factor: 3.281

8.  Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy.

Authors:  Shweta Bhatia; Rimi Shukla; Sri Venkata Madhu; Jasvinder Kaur Gambhir; Krishna Madhava Prabhu
Journal:  Clin Biochem       Date:  2003-10       Impact factor: 3.281

9.  Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia.

Authors:  Brian G DeRubertis; Matthew Pierce; Evan J Ryer; Susan Trocciola; K Craig Kent; Peter L Faries
Journal:  J Vasc Surg       Date:  2008-01       Impact factor: 4.268

Review 10.  Abnormal angiogenesis in diabetes mellitus.

Authors:  Alexandra Martin; Michael R Komada; David C Sane
Journal:  Med Res Rev       Date:  2003-03       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.